Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1157618 | 0.93 | SLC6A2 (0.50) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL22029800 | 0.89 | SLC6A2 (0.50) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL3385591 | 0.85 | SLC6A2 (0.56) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| Hydrogen Peroxide SCHEMBL17137759 | 0.84 | TRPA1 (0.47) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL31345277 | 0.83 | TRPA1 (0.46) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL872871 | 0.83 | SLC6A2 (0.54) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL7492795 | 0.81 | SLC6A2 (0.52) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL8025855 | 0.81 | LMNA (0.54) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL313697 | 0.81 | SLC6A2 (0.52) | SLC6A2TAAR1LMNACYP2D6TRPA1 | |
| SCHEMBL7929657 | 0.81 | SLC6A2 (0.52) | SLC6A2TAAR1LMNACYP2D6TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7132480-B2 | Compositions for use in golf balls | ACUSHNET COMPANY (US) | 2006-11-07 | — | — | US | claimed |
| US-20040219994-A1 | Compositions for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| US-20260034763-A1 | COMPOSITE TEXTILES AND ARTICLES OF FOOTWEAR FORMED THEREFROM | NIKE INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12329237-B2 | Composite structures including a bonding layer and methods of making the composite structure | NIKE, INC. (US) | 2025-06-17 | — | — | US | disclosed |
| US-12269947-B2 | Multi-layered structures and uses thereof | NIKE, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| EP-4155062-B1 | METHOD OF FORMING AN OUTSOLE | NIKE INNOVATE CV (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-4060004-B1 | COMPOSITE STRUCTURES INCLUDING A BONDING LAYER AND METHODS OF MAKING THE COMPOSITE STRUCTURE | NIKE INNOVATE CV (US) | 2024-05-29 | — | — | EP | disclosed |
| US-11975517-B2 | Color change materials, methods of making, methods of use, and articles incorporating the color change materials | NIKE, INC. (US) | 2024-05-07 | — | — | US | disclosed |
| US-11903440-B2 | Multi-layered structures and uses thereof | NIKE, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| EP-4196344-B1 | COMPOSITE TEXTILES AND ARTICLES OF FOOTWEAR FORMED THEREFROM | NIKE INNOVATE CV (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-4286157-A2 | COMPOSITE TEXTILES AND ARTICLES OF FOOTWEAR FORMED THEREFROM | NIKE Innovate C.V. (US) | 2023-12-06 | — | — | EP | disclosed |
| US-20040220356-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040219994-A1 | Compositions for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220377-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220376-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220373-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220357-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220371-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040214661-A1 | Compositions for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034763-A1 | COMPOSITE TEXTILES AND ARTICLES OF FOOTWEAR FORMED THEREFROM | PLOD1, COL14A1, COL1A1 | SLC6A2 4129/4885TAAR1 2624/4885LMNA 3296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.